NFT
PCVX icon

Nan Fung Trinity’s Vaxcyte PCVX Stock Holding History

Nan Fung Trinity’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.15M Hold
122,930
– – 0.71% 43
2026
Q1 		$7.14M Sell
122,930
-20,000
-14% -$1.09M 0.78% 42
2025
Q4 		$6.59M Buy
142,930
+38,680
+37% +$1.73M 0.52% 57
2025
Q3 		$3.76M Hold
104,250
– – 0.37% 56
2025
Q2 		$3.39M Buy
+104,250
New +$3.42M 0.41% 50

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nan Fung Trinity's PCVX Position: Q2 2026 in Review

Nan Fung Trinity held its Vaxcyte (PCVX) position steady in Q2 2026 at 122,930 shares worth $7.15M. The position accounts for 0.71% of the portfolio, ranked #43.

Nan Fung Trinity first reported a position in PCVX in Q2 2025 and has held it in 5 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Nan Fung Trinity held 122,930 shares of Vaxcyte worth $7.15M as of Q2 2026.
  • Nan Fung Trinity left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up 0.71% of Nan Fung Trinity's portfolio in Q2 2026, its #43 holding.
  • Nan Fung Trinity first reported a position in Vaxcyte in Q2 2025 and has held it in 5 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Nan Fung Trinity's 13F filing for Q2 2026, filed 24 Jul 2026.